Industry News
Clinical Trial Activity Report (CTAR) 2025
International investment grows in Australian clinical trials Global investment in the Australian clinical trials sector increased in 2025 according to Bellberry’s Clinical Trials Activity Report (CTAR) released today. Data contained in the 2025 CTAR shows there’s been growth in investment from the USA, Europe (including the UK), China and the rest of Asia. Since 2019, […]
Read More
Impact Report 2025
We’re proud to share Bellberry’s 2025 Impact Report – our first report bringing together key insights, data and achievements from the past year. Our stories from 2025 highlight how we continue to support ethical research and promote best practice across the sector, while giving back to the medical research community. This report reflects the collective […]
Read More
Clinical Trial Activity Report (CTAR) 2024
Report highlights international confidence in Australian clinical trials Global investment in Australian clinical trials is strong, with two thirds of Australian clinical trials, reviewed by Bellberry, funded by international companies according to its 2024 Clinical Trials Activity Report (CTAR). Bellberry is Australia’s largest ethics and scientific reviewer of research involving humans reviewing approximately 40% of […]
Read More
Clinical Trial Activity Report (CTAR) 2023
International investment strong in Australian early phase trials Overseas companies invest in two-thirds of all Australian clinical trials reviewed by Australia’s largest reviewer of human research, Bellberry, according to its Clinical Trial Activity Report (CTAR). Bellberry reviews more than 40% of CTN (Clinical Trial Notification) trials in Australia and each year releases its CTAR on […]
Read More
Bellberry Clinical Trial Activity Report 2021
On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report 2021. This second annual publication represents a significant proportion of the Australia wide CTN trial activity across the development lifecycle. It demonstrates capability and capacity in a broad range of research areas. The report also captures the originating funding location […]
Read More
Bellberry receives Australian first recognition
Bellberry awarded AAHRPP accreditation Bellberry has become the first organisation in Australia to achieve international accreditation for excellence and ethically sound processes in running Human Research Ethics Committees (HRECs). The recognition has come from the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is based in the USA. The AAHRPP site accreditation team […]
Read More
Crossover Conference Papers Published
In October 2014 Bellberry hosted the Crossover conference, an international expert scientific meeting that addressed the challenges of early treatment switching in clinical trial design for oncology. A further scientific meeting in 2015 allowed for the development and launch of best practice guidelines for trial design and statistical methods from an international expert panel. Bellberry […]
Read More